Crystal Structure of p38a Mitogen-Activated Protein Kinase in Complex with a Pyrazolopyridazine Inhibitor
收藏Protein Data Bank Japan2024-02-21 更新2026-03-21 收录
下载链接:
https://pdbj.org/mine/summary/3itz
下载链接
链接失效反馈官方服务:
资源简介:
Crystal Structure of p38a Mitogen-Activated Protein Kinase in Complex with a Pyrazolopyridazine Inhibitor Descriptor: 4-chloro-N-cyclopropyl-3-{[1-(2,6-difluorophenyl)-1H-pyrazolo[3,4-d]pyridazin-4-yl]amino}benzamide, Mitogen-activated protein kinase 14 Authors: Mohr, C, Jordan, S. Deposit date: 2009-08-28 Release date: 2010-03-02 Last modified: 2024-02-21 Method: X-RAY DIFFRACTION (2.25 Å) Cite: Part 2: Structure-activity relationship (SAR) investigations of fused pyrazoles as potent, selective and orally available inhibitors of p38alpha mitogen-activated protein kinase. Bioorg.Med.Chem.Lett., 20, 2010
与吡唑并哒嗪类抑制剂结合的p38α丝裂原活化蛋白激酶(Mitogen-Activated Protein Kinase)晶体结构。抑制剂标识符:4-氯-N-环丙基-3-{[1-(2,6-二氟苯基)-1H-吡唑并[3,4-d]哒嗪-4-基]氨基}苯甲酰胺,对应靶点为丝裂原活化蛋白激酶14(Mitogen-activated protein kinase 14)。作者:Mohr, C、Jordan, S。提交日期:2009年8月28日,发布日期:2010年3月2日,最后修改日期:2024年2月21日。实验方法:X射线衍射(X-RAY DIFFRACTION),分辨率2.25埃(Å)。引用文献:第二部分:融合吡唑类作为强效、选择性且可口服的p38α丝裂原活化蛋白激酶抑制剂的构效关系(Structure-Activity Relationship,SAR)研究。《Bioorg.Med.Chem.Lett.》,第20卷,2010年。
创建时间:
2009-08-28



